A Randomized, Placebo‐Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome

BACKGROUND: New pharmacological targets are needed for restless legs syndrome. Preclinical data suggest that a hypoadenosinergic state plays an important pathogenetic role. OBJECTIVE: The objective of this study was to determine whether inhibitors of equilibrative nucleoside transporters, for exampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia‐Borreguero, Diego, Garcia‐Malo, Celia, Granizo, Juan José, Ferré, Sergi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530834/
https://www.ncbi.nlm.nih.gov/pubmed/34137476
http://dx.doi.org/10.1002/mds.28668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530834/
https://www.ncbi.nlm.nih.gov/pubmed/34137476
http://dx.doi.org/10.1002/mds.28668

Ejemplares similares